Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Shenzhen's HeliTec to Co-Develop Archer DX Oncology Assays in China

publication date: Apr 5, 2017
HeliTec, a Shenzhen precision medicine company, will partner with Colorado's Archer DX to co-develop oncology diagnostic kits for China. The two companies are well known to each other. HeliTec's Co-founder and Chief Scientist, Zongli Zheng, PhD, invented technology that is central to Archer DX's next-gen assays. Founded in 2016, HeliTec focuses on innovative, sequencing-based diagnostics. It recently started the PANO-Seq™ project, which will look for molecular traces of malignancy in early tumors. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital